Artikel ; Online: Clonidine in pediatric anesthesia: the new panacea or a drug still looking for an indication?
Current opinion in anaesthesiology
2019 Band 32, Heft 3, Seite(n) 327–333
Abstract: Purpose of review: Clonidine, an α2-receptor agonist is a widely used drug in pediatrics with a large scope of indications ranging from prevention of postoperative emergence agitation, analgesia, anxiolysis, sedation, weaning to shivering. In the era of ...
Abstract | Purpose of review: Clonidine, an α2-receptor agonist is a widely used drug in pediatrics with a large scope of indications ranging from prevention of postoperative emergence agitation, analgesia, anxiolysis, sedation, weaning to shivering. In the era of 'opioid-free' medicine with much attention be directed toward increasing problems with opioid use, clonidine due to its global availability, low cost and safety profile has become an even more interesting option. Recent findings: Increasing evidence from randomised clinical trials support the use of clonidine in healthy children in the perioperative setting. Clonidine appears to significantly reduce postoperative emergence agitation, opioid consumption, shivering, nausea and vomiting. In addition, emerging evidence support the use of clonidine for sedation of critically ill children in ICUs. In this review, the current evidence for clonidine in pediatrics is described and analyzed including a meta-analysis for prevention of emergence agitation. Summary: Clonidine appears a safe and beneficial drug with moderate to high-quality evidence supporting its use in pediatric anesthesia. However, for some indications and populations such as children younger than 12 months old and those with hemodynamic instability, there is an urgent need for high-quality trials. |
---|---|
Mesh-Begriff(e) | Adrenergic alpha-2 Receptor Agonists/administration & dosage ; Adrenergic alpha-2 Receptor Agonists/adverse effects ; Age Factors ; Anesthesia/adverse effects ; Anesthesia/methods ; Child ; Clonidine/administration & dosage ; Clonidine/adverse effects ; Emergence Delirium/etiology ; Emergence Delirium/prevention & control ; Humans ; Patient Selection ; Postoperative Nausea and Vomiting/etiology ; Postoperative Nausea and Vomiting/prevention & control ; Randomized Controlled Trials as Topic ; Shivering/drug effects |
Chemische Substanzen | Adrenergic alpha-2 Receptor Agonists ; Clonidine (MN3L5RMN02) |
Sprache | Englisch |
Erscheinungsdatum | 2019-05-02 |
Erscheinungsland | United States |
Dokumenttyp | Journal Article ; Review |
ZDB-ID | 645203-6 |
ISSN | 1473-6500 ; 0952-7907 |
ISSN (online) | 1473-6500 |
ISSN | 0952-7907 |
DOI | 10.1097/ACO.0000000000000724 |
Datenquelle | MEDical Literature Analysis and Retrieval System OnLINE |
Zusatzmaterialien
Kategorien
Verfügbar in ZB MED Köln/Königswinter
Zs.A 2564: Hefte anzeigen | Standort: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (2.OG) ab Jg. 2022: Lesesaal (EG) |
Über subito bestellen
Dieser Service ist kostenpflichtig (siehe Lieferbedingungen von subito). Bestellungen, die einen Artikel nebst Supplementary Material umfassen, werden grundsätzlich wie mehrfache Bestellungen bearbeitet. Gebühren fallen in diesen Fällen für jede einzelne Bestellung an.